In linear mixed models , the MAPS intervention led to significant reductions in perceived stress ( P = .004 ) and marginal reductions in depressive symptoms ( P = .094 ) , as well as significant reductions in proinflammatory gene expression ( P = .009 ) and inflammatory signaling ( P = .001 ) at postintervention .